“So, what do you do?”

“I’m a financial advisor.” (Not true.)

“Oh, so you pick stocks?”

“Yep!” (Also not true.)

Anyone who knows me will not be surprised to hear that I read “Atomic Habits”…again. In 2018, James Clear wrote this remarkable book that has reportedly been purchased every 15 minutes since publication*. Additionally, his 3-2-1 Thursday newsletter is followed by more than 2 million people. Before I finish this blog, he will have sold a couple more books!

Why is it such a great book and so widely read and referenced? Well, he has organized dozens of concepts into a compelling approach to building better habits. It is digestible and actionable.

James offers hundreds of powerful quotes and thoughts, so it is hard to imagine implementing them all. But here’s one I find particularly compelling, which is relevant for financial advisors: “You do not rise to the level of your goals. You fall to the level of your systems.”

As a parent, I try to encourage my daughters to be inquisitive and develop cognitive skills by answering their questions with explanations that encourage conversation. Note that I said, “try,” because I’m certainly guilty of looking at them in the rearview mirror and letting out a, “Because I said so!” from time to time.

Pretty much everyone has experienced the agony having their TV watching interrupted by the ubiquitous pharmaceutical advertisement. In fact, they have become so commonplace that an assortment of entertaining spoofs have been created, like this one.

As the video above highlights, one of the memorable aspects for many of these medications is the absurdly long list of expected and potential side effects. Now, I respect the fact that these disclosures are important in providing consumers the necessary information to make an informed decision, but that doesn’t eliminate the irony of risking death for seasonal allergy relief.

After enduring yet another round of drug ads during a recent weekend of baseball, I was struck by the similarities between prescription medication and the stock market. Both are designed to address a specific problem, from eczema to paying for long-term healthcare and education expenses. Both also have side effects.

Imagine your client losing 20% of the value of their investment, yet receiving a capital gain distribution that’s also a double-digit percentage. Impossible you say? Well, for some mutual fund investors that is exactly the scenario they face as we approach the U.S. tax filing deadline.

What lessons can we glean from 2022 and the sticker shock many investors are undoubtedly facing?